Sumavel News
Most Popular Sumavel Story
Zogenix rounds up $51M for product roll-out
Zogenix has ginned a hefty $51 million Series B preferred stock financing to fund the roll-out of the company's first product. Clarus Ventures and Domain Associates co-led the round, and were joined Read more...
Latest Headlines
- September 23, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
